{"title":"阿尔茨海默病的预后是由上下波动的发病率泊松分布捕获的","authors":"R. Shanmugam","doi":"10.3844/AMJSP.2013.150.159","DOIUrl":null,"url":null,"abstract":"Alzeimer disease is a daunting nightmare to both the medical and families of the patients. Tireless efforts are made by the medical researchers to treat Alzheimer’s patients. The Alzhiemer patients’ data provides clues about its prognosis and they can be identifies when the data are analyzed and understood correctly. The data analysis is a first step in the path to breakthrough treatment. Towards this aim, this article introduces a new statistical distribution and calls it Down-Upsized Incidence Poisson Distribution (DUIPD). The properties of DUIPD are obtained and illustrated to interpret the patterns in the prognosis of two group of Alzheimer’s patients. In one group, the patients received a doseage of lecithin and other in the control group received placebo drug.","PeriodicalId":89887,"journal":{"name":"American medical journal","volume":"4 1","pages":"150-159"},"PeriodicalIF":0.0000,"publicationDate":"2013-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3844/AMJSP.2013.150.159","citationCount":"0","resultStr":"{\"title\":\"Alzheimer’s Disease Prognosis is Captured by a Down-Upsized Incidence Poisson Distribution\",\"authors\":\"R. Shanmugam\",\"doi\":\"10.3844/AMJSP.2013.150.159\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Alzeimer disease is a daunting nightmare to both the medical and families of the patients. Tireless efforts are made by the medical researchers to treat Alzheimer’s patients. The Alzhiemer patients’ data provides clues about its prognosis and they can be identifies when the data are analyzed and understood correctly. The data analysis is a first step in the path to breakthrough treatment. Towards this aim, this article introduces a new statistical distribution and calls it Down-Upsized Incidence Poisson Distribution (DUIPD). The properties of DUIPD are obtained and illustrated to interpret the patterns in the prognosis of two group of Alzheimer’s patients. In one group, the patients received a doseage of lecithin and other in the control group received placebo drug.\",\"PeriodicalId\":89887,\"journal\":{\"name\":\"American medical journal\",\"volume\":\"4 1\",\"pages\":\"150-159\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3844/AMJSP.2013.150.159\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American medical journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3844/AMJSP.2013.150.159\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American medical journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3844/AMJSP.2013.150.159","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Alzheimer’s Disease Prognosis is Captured by a Down-Upsized Incidence Poisson Distribution
Alzeimer disease is a daunting nightmare to both the medical and families of the patients. Tireless efforts are made by the medical researchers to treat Alzheimer’s patients. The Alzhiemer patients’ data provides clues about its prognosis and they can be identifies when the data are analyzed and understood correctly. The data analysis is a first step in the path to breakthrough treatment. Towards this aim, this article introduces a new statistical distribution and calls it Down-Upsized Incidence Poisson Distribution (DUIPD). The properties of DUIPD are obtained and illustrated to interpret the patterns in the prognosis of two group of Alzheimer’s patients. In one group, the patients received a doseage of lecithin and other in the control group received placebo drug.